Four years of early benefit assessment of new drugs in Germany : a qualitative study on methodological requirements for quality of life data
Christine Blome, Matthias Augustin, Hidayet Metin, David Lohrberg
| Year of publication: |
March 2017
|
|---|---|
| Authors: | Blome, Christine ; Augustin, Matthias ; Metin, Hidayet ; Lohrberg, David |
| Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 18.2017, 2, p. 181-193
|
| Subject: | AMNOG | Quality of life | Qualitative Research | Health technology assessment | Early benefit assessment | Comparative effectiveness research | Deutschland | Germany | Lebensqualität | Gesundheitswesen | Health care system | Qualitative Methode | Qualitative method | Kosten-Nutzen-Analyse | Cost-benefit analysis | Gesundheit | Health | Arzneimittel | Pharmaceuticals | Gesundheitskosten | Health care costs |
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1007/s10198-016-0765-6 [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10011867761